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Simple Summary: Some neoplasia—such as adrenal and thyroid glands tumors—have been
associated with “tumor thrombi” both in humans and dogs. The detection and characterization
of these venous tumor thrombi is important for both surgical planning and prognosis. In human
medicine, contrast-enhanced ultrasonography (CEUS) is considered an accurate diagnostic technique
for differentiating malignant from benign portal vein thrombosis in hepatocellular carcinomas.
Data regarding the characteristics of tumor thrombi in dogs are currently lacking. Therefore, the aim
of this study was to assess the feasibility of CEUS for the characterization of malignant venous
thrombosis in dogs. On the basis of our results, CEUS appeared to be useful in the detection of
malignant intravascular invasion; contrast uptake of the thrombus was present in all cases. In addition,
CEUS may clearly detect newly formed vessels within the thrombus, and arterial-phase enhancement
and washout in the venous phase were the main features in malignant thrombosis in our dogs.
As CEUS is an easy to perform, noninvasive technique, its application in the detection of malignant
thrombosis in dogs may be used to improve the diagnosis in oncological canine patients.
Abstract: Tumors of adrenal and thyroid glands have been associated with vascular invasions—so-called
tumor thrombi, both in humans and dogs. The detection and characterization of venous thrombi is an
important diagnostic step in patients with primary tumors for both surgical planning and prognosis.
The aim of this study was to describe the use of contrast-enhanced ultrasonography (CEUS) for
the characterization of tumor thrombi. Dogs with tumor thrombus who underwent bi-dimensional
ultrasound (B-mode US) and CEUS were included. Seven dogs were enrolled in this retrospective
case series. On B-mode US, all thrombi were visualized, and vascular distension and thrombus-tumor
continuity were seen in three and two cases, respectively. On color Doppler examination, all thrombi
were identified, seemed non-occlusive and only two presented vascularity. On CEUS, arterial-phase
enhancement and washout in the venous phase were observed in all cases. Non-enhancing areas were
identified in the tumor thrombi most likely representing non-vascularized tissue that could potentially
be embolized in the lungs after fragmentation of the tumor thrombi. On the basis of these preliminary
study, CEUS appeared to be useful for the characterization of malignant intravascular invasion.
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1. Introduction
Tumor thrombi are defined as tumors extending into a vessel—typically a vein. It is crucial
to distinguish tumor thrombi from non-malignant thrombi in the setting of neoplasia, as this often
impacts staging and treatment approaches [1–6]. In particular, thyroid carcinomas have the tendency to
infiltrate adjacent structures (including vessels), and the risk of metastases increases when the thyroid
vein is occupied by a neoplastic thrombus [4,6]. Tumors of the adrenal glands have been associated
with tumor thrombi in humans and dogs [1–3,5]; previous studies reported that dogs with caval tumor
thrombi may have a poorer long-term prognosis [3,7]. In addition, the invasion of the caudal vena
cava is associated with higher postoperative mortality rate—especially when invasion is extensive
(thrombi extending cranial to the hepatic hilus) [5]. Fast and less invasive surgical techniques have
been recently described in dogs with caval invasion, with good results [8,9], despite the presence of
a post-hepatic thrombus or long caval occlusion time [9]. According to another recent study, dogs
with post-diaphragmatic tumor thrombi still showed a worse prognosis [10]. Therefore, detection and
characterization of tumor thrombi is of great importance in patients with primary tumors for both
surgical planning and prognosis.
Ultrasound examination is fast and less invasive method to examine intra-abdominal structure,
thyroid lobes and adjacent vessels, showing high sensitivity (100%) and specificity (96%) in detecting
vascular invasion [11]. In another study concerning adrenal tumors, the sensitivity and specificity
of abdominal US for the detection of a caval thrombus were 80 and 90%, respectively [3], while
contrast-enhanced CT showed 92% sensitivity and 100% specificity for intraluminal invasion from
adrenal masses in dogs [12]. Color flow Doppler (CFD) examination of the intravascular formation can
be useful in diagnosing tumor thrombi, but the vascularization is often so poor that no signal can be
seen inside the lesion [13,14]. In humans, contrast-enhanced ultrasonography (CEUS) is considered
an accurate diagnostic technique for the characterization of portal vein thrombosis complicating
hepatocellular carcinoma, with high sensitivity (88–97.7%), 100% specificity and very good accuracy
(92.5–95.5%) in distinguishing benign from tumor thrombi [13–17]. In dogs, the presence of thrombosis
associated with adrenal and thyroid masses is most likely to be malignant, as these tumors have
the tendency of invade the vessels and adjacent tissues [1–7]. Nevertheless, CEUS could be useful
in these cases to confirm the anatomic continuity with the tumor and to assess the homogeneity
of the tumor thrombus in order to anticipate the possibility of fragmentation, which could lead
to pulmonary thromboembolism and/or could represent a surgical complication, as previously
described [10]. Despite the high sensitivity and specificity of CT in detecting vascular invasion in
dogs [11], this modality may not be performant in the characterization of the homogeneity of the
thrombus and also for detection of potential endothelial invasion, because of frequent streamlining
artefacts and lesser spatial resolution compared to CEUS. For these reasons, CEUS could represent a
useful technique for the detection and characterization of tumor thrombi in dogs.
The purpose of this study was to describe CEUS features of tumor thrombi in dogs, with
particular attention to the risk of fragmentation and endothelial invasion and compare them with their
conventional ultrasound (US) and CFD characteristics.
2. Materials and Methods
Medical records of dogs admitted to the Veterinary Teaching Hospital of the University of Bologna
from January 2012 through January 2016 were reviewed and dogs with primary masses and associated
venous thrombi were selected. Dogs were included in the study if they had a complete US examination
of the mass and associated thrombus, including B-mode US, CFD examination and CEUS. Only dogs
with a cytological or histological diagnosis of the primary mass, associated venous thrombus or both
were selected.
The following information were recorded for each case: breed, sex, age, anamnesis, results of
physical examination, laboratory tests and histological or cytological findings.
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Two-dimensional US, CFD and CEUS images were reviewed off-line. Bi-dimensional findings
recorded were: Localization, shape, dimension, echostructure of the primary lesion, presence of
intravascular thrombus showing anatomic continuity with the primary lesion and dilation of the
invaded vessel. The evaluated CFD findings were: Presence of residual flow within the invaded
vessel and presence of intralesional signal within the primary lesion and the thrombus. Finally,
CEUS findings evaluated were: contrast uptake (present or absent), aspect of the contrast uptake
(homogeneous/heterogeneous), margination of the thrombus (regular and well-defined/irregular and
ill-defined), comparison between timing in contrast uptake by the thrombus and the invaded vessel
and comparison between timing in contrast uptake by the thrombus and the primary lesion.
Histological or cytological findings of the primary tumor or of the thrombus, when available,
were recorded. Samples were collected by ultrasound-guided fine needle aspiration (FNA) and/or
tissue core biopsy (TB) or at necropsy.
3. Results
Seven dogs met the inclusion criteria. The median age was 11 (7–13) years, and the median body
weight was 27 (9–33) kg. Information regarding the signalment and clinical signs are summarized in
Table 1.
Bi-dimensional US and CFD examinations were performed using an ultrasound unit (iU22
ultrasound system, Philips Healthcare, Monza, Italy) equipped with different micro-convex, convex
and linear array probes of different frequencies (2–9 MHz). For the CEUS examination, a linear array
probe (3–9 MHz) was used. Contrast-enhanced US was performed by intravenously injecting 0.05
mL/kg (0.02 mL/lb) of a second generation US contrast medium (SonoVue, Bracco® diagnostic, Milano,
Italy) through an indwelling cephalic venous catheter, followed by a rapid immediate bolus of 5 mL
saline. The arrival of the contrast medium at the level of the target organ was then visualized using
dedicated imaging software of the ultrasound machine that selectively displaces the signal deriving
only from the contrast medium, allowing perfect definition of the perfusion pattern of the region of
interest. Bi-dimensional US, CFD and CEUS findings are summarized in Table 2.
Contrast-enhanced US was feasible in all dogs. In every case, contrast uptake from the thrombus
was identified. Moreover, a feeding vessel was clearly visible inside the thrombus in two dogs
(Figure 1).
Figure 1. (A) Two-dimensional and (B,C) contrast-enhanced images of malignant thrombosis involving
the caudal vena cava in a dog with right adrenal carcinoma (case 4). (A) Hyperechoic, solid thrombus is
seen in the caudal vena cava (CVC), with a focal dilation of the vessel; (B) evidence of the enhancement
of a tortuous newly formed vessel inside the thrombus (*), while caudal vena cava is still anechoic
(Anticipated wash-in); (C) inhomogeneous wash out of the thrombus (dotted) while the contrast
medium is still present on the lumen of the caudal vena cava (CVC).
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Table 1. Signalment and clinical signs of a population of dogs with neoplastic venous thrombosis.
Case No Breed Sex Age (Years) Weight (kg) Clinical Symptoms CBC and Biochemistry Abnormalities Type of Tumor
1 Mixed FS 10 27 Swelling of the neck, sudden change of voice Elevated serum alkaline phosphatase Thyroid carcinoma




MN 7 15 PU/PD, polyphagia abdominal distension Elevated serum alkaline phosphatase Adrenal carcinoma
4 Mixed F 10 9 Abdominal distension, diarrhea None Adrenal carcinoma
5 Boxer M 11 32 PU/PD, diarrhea Elevated serum alkaline phosphatase Adrenal pheochromocytoma
6 Labrador FS 13 32 PU/PD, polyphagia abdominal distension Elevated serum alkaline phosphatase Adrenal pheochromocytoma
7 Mixed MN 13 33 PU/PD, diarrhea Elevated serum alkaline phosphatase Retroperitoneal liposarcoma
FS—female spayed; MN—male neutered; F—female intact; M—male intact; PU/PD—polyuria and polydipsia; CBC—complete blood count.
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The aspect of the uptake was homogeneous in the two cases originating from the thyroid
and heterogeneous with large non-enhancing areas in all abdominal cases. The margination of the
thrombus was regular and well-defined in two cases and irregular and ill-defined in the other five dogs.
All thrombi showed an earlier contrast uptake compared to the timing of contrast medium arrival
within the venous vessel (Figure 2). In 3 dogs, direct comparison of CEUS behavior of the primary
tumor and the thrombus was possible on the same field of view. In every case, a simultaneous contrast
uptake from the lesions was observed (Figure 3).
Two dogs (one thyroid mass, case 1; one adrenal mass, case 3) had surgical removal of the
primary tumor and the thrombus. Histopathological diagnosis was consistent with solid-follicular
thyroid carcinoma with neoplastic vascular invasion in the first case and with adrenocortical carcinoma
associated with intravascular neoplastic thrombosis in the other one. Two dogs died few months after
the US; necropsy showed a thyroid carcinoma with neoplastic invasion of the thyroid vein in one case
(case 2) and a cortical adrenal gland carcinoma with neoplastic thrombotic caval invasion in the other
(case 4). Necrotic areas within the tumor thrombus were detected at histology in one case (case 3) and
endothelial invasion in another case (case 1).
In 3 cases the neoplastic mass extending into the caval vein was associated with multiple hepatic
lesions detected on US. In these cases, cytology of the liver nodules suggested adrenal medullary
neuroendocrine tumor (cases 5 and 6) and retroperitoneal liposarcoma (case 7) as primary diagnoses.
Surgery was recommended, but declined by the owners; accordingly, histopathology of the intravascular
mass was not available for these last three cases, and the diagnosis of tumor thrombi in these cases was
only presumptive.
Figure 2. (A–D) Representative contrast-enhanced ultrasound sequences of malignant thrombosis
involving the caudal vena cava in a dog with right adrenal carcinoma (case 3). Each sequence illustrates
contrast enhancement on the left and the gray scale image on the right. (A) Left image shows the
contrast medium in the celiac and mesenteric arteries (*) (Arterial phase). The grayscale image shows
the thrombus in the vessel; (B) In the left image, a diffuse enhancement within the thrombus is seen,
while caudal vena cava is still anechoic (Anticipated wash-in); (C) The contrast medium arrives in the
lumen of the caudal vena cava and the thrombus is not detectable; (D) On the left image, the thrombus
shows wash out (dotted lines) while the contrast medium is still present on the lumen of the caudal
vena cava (CVC).
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Figure 3. (A) Two-dimensional and (B) contrast-enhanced images of malignant thrombosis involving
the thyroid in a dog with thyroid carcinoma (case 1). (A) The thyroid mass (arrows head) invades the
lumen of the right thyroid vein (dotted); (B) contrast-enhanced ultrasound shows synchronous contrast
uptake of the primary thyroid mass and the thrombus inside the thyroid vein.
4. Discussion
In this study, CEUS could identify all tumor thrombi, whereas B-mode US allowed their
visualization but could not establish the continuity with the primary tumor in every case. In addition,
CEUS could better describe the vascularity of the tumor thrombi compared to CFD.
Conventional B-mode US is a fast and noninvasive tool to examine intra-abdominal structures,
superficial neck structures, thyroid lobes and adjacent vessels. A recent study showed that conventional
US is 100% sensitive and 96% specific in detecting vascular invasion of the caudal vena cava in dogs
with adrenal gland tumors [11]. However, small thrombi or small vessels are difficult to accurately
evaluate with US [11]. Moreover, neoplastic thrombosis and simple vascular thrombosis due to clot
formation are difficult to differentiate on US [13].
Conventional B-mode US detected venous thrombosis in all patients of our study. Bi-dimensional
features of tumor thrombi have been previously reported in literature and they are characterized by
continuity between the primary mass and the thrombus [18,19] and dilation of the vessel in the site of
thrombosis, which can be associated with rupture or infiltration of the vessel wall [20]. Only two of the
seven thrombi were clearly connected with the primary mass, and dilation of the vessel was seen in
four of the seven cases. This could be related to the position of the primary tumor itself, i.e., thyroid
and adrenal glands that are smaller to image and require good knowledge of the regional anatomy
(thyroid vessels), the mass effect on adjacent vascular structures or technically more challenging to
reach because of the depth of the organ (adrenal) [21]. None of them presented visible rupture of the
vessel wall.
Color-Doppler examination of the thrombus may be helpful in detecting intralesional signal due
to presence of newly formed tumoral vessels, suggesting a neoplastic origin of the thrombus. However,
this technique is limited by the low sensitivity of Doppler in detecting small vessels, low velocity blood
flow and microvascularization in general [14]. In this case series, CFD was poorly sensitive in detecting
thrombus vascularization in only two dogs was a Doppler signal evident into the thrombus. In humans
with hepatocellular carcinoma, the detection of arterial flow within the thrombus using CFD is highly
specific for a neoplastic nature of the thrombosis, but its sensitivity is low (20–51%) [13,14].
In human medicine, CEUS showed higher sensitivity in detecting vascularized tumor thrombosis
when compared to CFD examination [14,15]. In humans, CEUS is also used to differentiate malignant
thrombosis from a simple benign thrombus. In patients with hepatocellular carcinoma, CEUS
shows high sensitivity (88–97.7%), specificity (100%) and accuracy (92.5–95.5%) in detecting and
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characterizing portal vein thrombosis, being the most sensitive imaging technique even when compared
to contrast-enhanced computed tomography (CT) [13,14,17]. The intrinsic sensitivity of CEUS is higher
than CT, as it allows single bubbles having the dimension of a red blood cell to be imaged and the
contrast between contrast-enhanced blood and tissue is very high [22]. In addition, CEUS is performed
in real time and allow to monitor continuously the contrast distribution, whereas in CT the selection
of the vascular phase, i.e., the timing of the acquisition compared to the intravenous injection of the
contrast agent, can influence the detection of thrombosis [15]. In small animals CT, the limited spatial
resolution and the possible presence of streamlining artifact could reduce the possibility to correctly
diagnose thrombosis [23], and CT may also be unable to detect endothelial invasion or evaluate the
risk of fragmentations, both important features for a correct surgical planning [10].
In dogs, some studies have been carried out in order to determine the utility of contrast-enhanced
CT in the detection of vascular luminal invasion by adrenal gland masses [12,24]. They showed high
sensitivity and specificity of CT (respectively 92% and 100%) for detection of tumor thrombi, with an
accuracy of 95%, and excellent agreement has been observed between CT signs of malignant thrombosis
and vascular invasion found at surgery or necropsy [24]. Nevertheless, there is only one preliminary
study in veterinary medicine comparing the use of US and/or CT for the evaluation of adrenal tumors
in dogs and the detection of tissue invasion or thrombus [25]. Two studies described CEUS pattern
of adrenal tumors in dogs [26,27], but a detailed description of the thrombus enhancement was
not provided.
In our case series, contrast uptake of the thrombus was considered the main feature of malignancy,
and it was present in all cases. Contrast-enhanced US may also clearly detect new-formed vessels
within the thrombus. Studies in humans, however, reported that CEUS may misdiagnose a benign
thrombus when some of its portion are revascularized, mimicking a vascularized malignant neoplastic
thrombosis [14].
For this reason, other features were evaluated. Particularly, the timing of thrombus enhancement
was always compared to the invaded vessel and in three cases to the primary neoplastic mass. Malignant
thrombi showed a contrast uptake synchronous with the primary mass while the enhancement was
always anticipated in the thrombus when compared to the invaded veins. This behavior is meant
to be a consequence of newly formed arterial vessels inside the malignant thrombi (early arterial
enhancement) that typically receive the contrast before it reaches the systemic venous system [13].
The aspect of the contrast uptake of the tumor thrombi was homogeneous in two dogs with
thyroid tumors, while was heterogeneous, with several non-enhancing areas within the thrombus in
the caval tumor thrombi. This aspect could reflect the presence of necrotic areas within the thrombus
(histologically confirmed in one case). The necrotic areas within a tumor thrombus could lead to its
fragmentation and predispose to pulmonary thromboembolism. For this reason, the possibility of a
thrombus to fragment should be taken in account when deciding the treatment, in case of surgery in
deciding the timing for the surgery and to formulate a prognosis.
Similarly, the possibility of CEUS to detect endothelial invasion could be extremely useful for
surgical planning, as, for instance, a cavectomy is required in case of endothelial invasion from the
neoplastic adrenal tissue. The irregular and ill-defined margination of the thrombus, with particular
attention to the portions adjacent to the vessel walls, could reflect the endothelial invasion, as confirmed
histologically in one of our cases.
This study has some limitations mainly related to its retrospective nature. First of all, the limited
number of cases associated with the absence of dogs affected by benign thrombi prevented the
possibility to evaluate the accuracy of CEUS in distinguishing benign from malignant thrombi. The lack
of histological confirmation of thrombus malignant origin in three cases and confirmation of necrotic
areas within the thrombus or endothelial invasion in only two cases are others limitations of this
study. Further studies, including cases of nonneoplastic thrombi, are needed in order to confirm the
peculiarity of CEUS features of malignant thrombi.
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5. Conclusions
In conclusion, this is the first report describing the use of CEUS to characterize intravenous
thrombosis in dogs with malignancies. On the basis of these preliminary experience, CEUS appeared
to be easy to perform and useful for the detection of malignant intravascular invasion. In particular,
the presence of an arterial-phase enhancement of the thrombus and a washout in the venous phase
were consistently identified for the malignant thrombi characterized in this study.
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